WASHINGTON, Aug. 4 -- The U.S. Department of Health and Human Services Food and Drug Administration has issued a notice, published in the Federal Register on July 31, 2024, entitled "Biosimilar User Fee Rates for Fiscal Year 2025." The notice was issued by Lauren K. Roth, Associate Commissioner for Policy. * * * SUMMARY: The Food and Drug Administration (FDA, Agency, or we) is announcing the rates for biosimilar user fees for fiscal year (FY) 2025. The Federal Food, Drug, and Cosmetic Act (F  more